The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions - Li, Xiang; Guo, Wenqiang; Chen, Jian; Tan, Gewen (Clinical pharmacology in drug development, 2024)
Keywords: abexinostat (CRA‐024781); bioequivalence; healthy subjects; histone deacetylase inhibitor (HDACi); pharmacokinetics